Search bioRxiv⌕ Search

Biology subjects

Oluwasemowo, O.

Publications and source records attributed to Oluwasemowo, O..

2 recordsLinked to original sources

A Selenium-Deficient Mouse Model of Mouse-Adapted SARS-CoV-2 Demonstrates Variant Emergence Observed in SARS-CoV-2 Pandemic Variants

Host selenium deficiency has been shown to generate novel genetic variants in RNA viruses. With the predicted rise of selenium deficiency globally, we sought to determine if host selenium deficiency can be a predictive factor for RNA virus variant emergence. We utilized a selenium-deficient BALB/c mouse model to investigate how host selenium status influences the emergence of viral variants in mouse-adapted SARS-CoV-2. Mice were maintained on control or selenium-deficient diets and subjected to sequential rounds of diet-matched viral passage to generate diet-specific virus populations. Deep sequencing of passaged viral populations revealed that selenium-deficient passage drove a marked increase in inter-host genomic heterogeneity and produced a distinct mutational profile relative to control passage. Eighteen mutations were identified as unique to selenium-deficient passage, including variants previously observed during natural human SARS-CoV-2 evolution. These mutations were largely maintained at sub-consensus frequencies, indicating that selenium deficiency can expand the viral quasispecies landscape that enrichs reservoirs of adaptive potential. To determine how this altered mutant spectrum affected pathogenesis, we challenged normal diet-fed adult and aged BALB/c mice with control- or selenium-deficient-passaged virus. Although overt differences in weight loss, survival, and viral burden were generally modest, selenium-deficient-passaged virus induced pronounced increases in antiviral cytokine expression. Together, these findings identify host selenium deficiency as a driver of RNA virus population diversification and show that nutritionally stressed animal models can reproducibly generate mutations observed in nature.

microbiology↗

Improved Zika virus plaque assay using Vero/TMPRSS2 cell line

Plaque assay is the gold standard for the quantification of viable cytopathic viruses like Zika virus (ZIKV). Some strains of ZIKV produce plaques that are very difficult to accurately visualize and count on the commonly used Vero cell line. From data generated in our lab, we became curious if Vero/TMPRSS2 cells may be a better alternative, therefore we compared the plaque forming units (PFU) of two strains of ZIKV on Vero/TMPRSS2 cells to those produced by Vero cells. We also compared the virus stock titer generated on Vero/TMPRSS2 cells to that generated by the Vero cell line. Although Vero cells generated higher quantity of ZIKV stocks, Vero/TMPRSS2 cells produced plaques with significantly improved morphology and visibility and may therefore be a better alternative to use for performing plaque assays for strains of ZIKV that are more difficult to titer on regular Vero cells.

microbiology↗